April 8th 2026
–
Riordan Clinic
–
On April 25, 2026, the Riordan Clinic will gather current and former staff, co-learners, supporters, community members, donors, and the general public to celebrate our 50th Anniversary Gala.
Providers such as myself, who have spent decades caring for patients with a cancer diagnosis, have much to thank the Riordan Clinic for. While we speak about functional and integrative medicine today, the practice of using testing to determine an individual patient’s specific deficiencies and therapies was pioneered by Dr. Riordan and the Center for the Improvement of Human Functioning long before it became the Riordan Clinic. Personalized medicine may now be a buzzword in oncology, but the Riordan Clinic has been doing this work for decades.
Integrative oncology is grounded in evidence-based medicine. Understanding how a certain nutrient may help reduce unwanted side effects of chemotherapy, or how best to support co-learners with personalized advice on diet, supplements, and other integrative therapies, requires careful consideration of the diagnosis, the individual sitting in front of you, and the treatment they are receiving.
Riordan Clinic is known internationally for studies on intravenous (IV) vitamin therapies in oncology, specifically high-dose IV vitamin C and its use alongside cancer care. In 1989, Dr. Riordan initiated the RECNAC Project, which sought to understand why cancer develops and how it can be approached safely. He focused on how nutrient deprivation affects the behavior of our cells and how the immune system’s response can be improved. Out of this work came multiple research papers, high-dose IV vitamin C protocols used around the world, studies on dendritic cell therapy, and other foundational contributions to integrative oncology.
As we look forward to the next 50 years, the landscape of oncology is shifting. We are seeing an increase in cancer diagnoses in patients under the age of 50. These cancers are often more aggressive and more challenging to treat compared to similar diagnoses in older populations. While we know about risk factors like obesity, alcohol consumption, smoking, and certain genetic mutations, these do not fully explain the rise in diagnoses across age groups.
Advances in conventional oncology have improved outcomes, and more individuals are living beyond their diagnosis. Survivorship is often the time when patients begin asking questions about what may have contributed to the cancer in the first place.
We know there is more to this story.
We continue to use testing methods championed by Dr. Riordan through our Bio-Center Lab, along with expanded testing for chronic infections, environmental exposures, heavy metals, and mycotoxins. These insights help us better understand what may have contributed to a colearner developing cancer. With data from thousands of co-learners, there is an opportunity to identify patterns that could help guide future research.
This work takes time and resources, and it requires the support of a broader community.
The Gala is not only a celebration, but an opportunity to support this work. It allows us to continue advancing research while also providing personalized care to new co-learners, with a goal of serving 1,000 new co-learners annually over the next 10 years.
We also recognize the barriers to receiving truly integrative support. One of the most common challenges our New Patient Coordinators hear is financial limitations. Many individuals navigating cancer care, including those who have explored other options without success, are unable to move forward due to cost.
We want to change that.
With your support, whether by attending the Gala or contributing in other ways, more co-learners can begin their journey toward health, healing, and hope.
The post Supporting the Future of Integrative Medicine appeared first on Riordan Clinic.
Read the full article here:
https://riordanclinic.org/2026/04/new-hope-for-long-covid-at-riordan-clinic-2/
